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A recent study revealed that ES (embryonic stem) cell lines
derived from the 129 murine strain carry an inactivating mutation
within the caspase 11 gene (Casp4) locus [Kayagaki, Warming,
Lamkanﬁ, Vande Walle, Louie, Dong, Newton, Qu, Liu, Heldens,
Zhang, Lee, Roose-Girma and Dixit (2011) Nature 479, 117–
121]. Thus, if 129 ES cells are used to target genes closely linked
to caspase 11, the resulting mice might also carry the caspase
11 deﬁciency as a passenger mutation. In the present study, we
examined the genetic loci of mice targeted for the closely linked
c-IAP (cellular inhibitor of apoptosis) genes, which were
generated in 129 ES cells, and found that, despite extensive
backcrossing into a C57BL/6 background, c-IAP1
−/− animals
arealsodeﬁcientincaspase11.Consequently,dataobtainedfrom
these mice should be re-evaluated in this new context.
Key words: 129 mouse strain, caspase 1, caspase 11, inhibitor of
apoptosis protein (IAP), lipopolysaccharide (LPS), sepsis.
INTRODUCTION
ES (embryonic stem) cell lines from the murine 129 strain
are frequently used to derive genetically modiﬁed mice [1]. A
recent report examining the role of caspase 1 in an endotoxin-
induced murine model of sepsis revealed that the resistance to
sepsis observed in caspase-1-targeted mice is largely due to a
naturally occurring inactivating mutation within the caspase 11
gene (Casp4) locus that originated from the 129-derived ES cell
line used in the creation of the mouse knockout [2]. This was
consistent with an earlier study attributing the resistance to septic
shock in the 129 strain of mice to differential expression of a gene
in the region of mouse chromosome 9 where the caspase 11 gene
is located [3].
Caspase 11, a mouse-speciﬁc caspase of the caspase 1
superfamily of cysteine proteases, has fundamental roles in the
regulation of apoptosis and inﬂammation [4–6]. Caspase 11 is
virtually undetectable in resting cells, but can be rapidly induced
by various inﬂammatory or cytotoxic stimuli [4]. Once activated,
caspase 11 can trigger caspase-1-dependent production of pro-
inﬂammatory cytokines in the immune response [4], and it can
also directly activate caspase 3, promoting cell death [7].
Inarecentstudy,sequenceanalysisofthecaspase11genefrom
several substrains of 129 mice revealed a 5 bp deletion within
the gene [2]. This deletion removes the splice acceptor sequence
of exon 7, resulting in a truncated transcript with exon 6 fused
directly to exon 8. Absence of exon 7 from the transcript creates a
frameshift mutation, resulting in a premature stop codon [2]. The
predicted protein product of the shortened caspase 11 transcript,
if expressed, would lack a large portion of its catalytic domain,
and would be expected to be non-functional [2].
Owing to the close genetic proximity of the genes for murine
caspase 1 (Casp1) and caspase 11 on chromosome 9, caspase-
1-null mice, which were generated experimentally using 129
ES cells [8,9], were additionally found to bear the caspase
11 mutation, and this co-segregation was maintained despite
extensive backcrossing into the caspase 11 wild-type murine
strain, C57BL/6 [2]. Since deletion of caspase 11 alone has been
shown to result in heightened resistance to sepsis [5], this makes
it important to distinguish between the relative contributions of
each protein to the inﬂammatory response. Indeed, the resistance
to sepsis in the caspase-1-deﬁcient caspase-11-mutated mice can
be reversed by expressing exogenous caspase 11, suggesting that
caspase 11 status is important for the phenotype [2].
Other genes targeted using 129-derived ES cells adjacent to
the caspase11 locus may co-segregatein 129 strains. Notably,the
genes encoding the c-IAP [cellular IAP (inhibitor of apoptosis)]
proteins c-IAP1 and c-IAP2, Birc2 and Birc3 respectively, are in
close proximity to the caspase 11 gene on mouse chromosome
9, and, as such, mice deﬁcient in c-IAP1 and c-IAP2 also
potentially carry the mutation in the caspase 11 locus. IAP
proteins are a broadly expressed group of intracellular factors
that function in a wide range of cellular processes, in addition to
their initially described role in the suppression of programmed
cell death [10]. An emerging role for the IAP proteins is
in the control of the innate immune response, functioning as
key enzymes in several signalling pathways [11]. Additionally,
in vivo data from the published c-IAP1
−/− and c-IAP2
−/− mice
[12] showed reduced serum levels of pro-inﬂammatory cytokines
and chemokines, compared with controls, when treated with
NOD1 and NOD2 ligands [13]. Furthermore, c-IAP1
−/− and c-
IAP2
−/− mice were found to be protected from a lethal dose of
LPS (lipopolysaccharide), suggesting a role in the response to
sepsis ([14], and K. Oetjen and C.S. Duckett, unpublished work).
Since the previously reported c-IAP1- and c-IAP2-targeted
mice were generated from 129 ES cells, this raised the possibility
that either or both of these strains might be also deﬁcient for
caspase 11. In the present study, we have examined this question
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and found that, despite extensive backcrossing, c-IAP1-targeted
mice, but not c-IAP2-deﬁcient animals, have the reported caspase
11 intronic inactivating deletion. We also show that this was not
due to differences in the 129 ES lines used to create the c-IAP-
targeted mice, because the caspase 11 mutation was found to be
penetrant in an extensive panel of 129 ES lines tested, which
included the lineages used in the targeting of both the c-IAP1 and
c-IAP2 genes. These data suggest ﬁrst that data obtained
from c-IAP1
−/− mice may need further evaluation, and secondly
that a selective pressure may exist for the maintenance of a wild-
type caspase 11 gene during normal development.
EXPERIMENTAL
Cells
C57BL/6 and 129 ES cell lines were maintained in high glucose
Dulbecco’sminimalessentialmedium(Invitrogen)supplemented
with 15% (v/v) fetal bovine serum (Harlan), 4 mM glutamine,
1 μM 2-mercaptoethanol, 1% MEM non-essential amino acids,
50 IU/ml penicillin, 50 μg/ml streptomycin and 1000 IU/ml
ESGRO (Millipore) on FVB/N mouse embryonic feeder cells
mitotically inactivated by irradiation. Before DNA extraction and
genotyping, ES cell lines were passaged twice on gelatin-coated
dishes to eliminate feeders from the cultures as described in [15].
MEF (mouse embryonic ﬁbroblast) cells were cultured in
Dulbecco’s modiﬁed Eagle’s medium (Mediatech) supplemented
with 10% (v/v) fetal bovine serum (Mediatech) and 2 mM
glutamine (Gibco) at 37◦C with 5% CO2. Matched c-IAP1 wild-
type and c-IAP1
−/− MEFs, prepared from littermate controls,
have been described previously [16].
Immunoblotting
Cell lysates from MEFs were prepared with Nonidet P40
lysis buffer (50 mM Tris/HCl, pH 8.0, 150 mM NaCl, 1%
Nonidet P40, 5 mM NaF and 1 mM Na3VO4) supplemented
with protease inhibitors for 30 min on ice to ensure complete
lysis. Protein quantiﬁcation was determined using the Bradford
assay (Bio-Rad Laboratories). Cell lysates of equal protein
concentrations were prepared in lithium dodecyl sulfate sample
buffer (Invitrogen) separated on denaturing NuPAGE 4–12%
polyacrylamide gradient gels, and transferred on to 0.2-μm-pore-
size nitrocellulose membranes (Invitrogen). Membranes were
blocked in 2% (w/v) non-fat dried milk powder in TBS-T
(Tris-buffered saline: 20 mM Tris/HCl and 135 mM NaCl, pH
7.6 with 0.1% Tween 20), followed by incubation overnight
at 4◦C with the following antibodies against the following:
caspase 11 (17D9, Novus Biologicals), c-IAP1 (1E1-1-10, Enzo
Life Sciences) and β-actin (AC-74, Sigma). After washing with
TBS-T,membraneswereincubatedwithsecondaryantibodiesfor
1 h at room temperature (20◦C). Enhanced chemiluminescence
(Pierce) was used to visualize the blots on HyBlot CL
Autoradiography ﬁlm (Denville Scientiﬁc).
RT (reverse transcription)–PCR
c-IAP1 wild-type or c-IAP
−/− MEFs were treated as indicated
with LPS, and cells were then washed with PBS. Total RNA
was isolated using the RNeasy minikit (Qiagen) following
the manufacturer’s instructions. RT with random hexamer
primers and MultiScribe
TM reverse transcriptase (Applied
Biosystems) was performed on 1 μg of total RNA. Full-length
caspase 11 cDNA was ampliﬁed using the primers 5
 -ATG-
GCTGAAAACAAACACCCT-3
  and 5
 -TCAGTTGCCAGG-
Figure 1 Somatic mutation of caspase 11 in c-IAP1-deﬁcient mice
(A)Schematicofmousechromosome9showingtherelativepositionsofthecaspase1,caspase
11,caspase12,c-IAP1andc-IAP2genes.Casp,caspase.(B)Alignmentofthesequencingdata





 . Products were resolved on 2% agarose gels
and images captured on Gel Doc
TM (Bio-Rad Laboratories). A
500 bp fragment of the caspase 11 sequence was ampliﬁed by
PCR from genomic DNA prepared from cell pellets using the
primers 5
 -GTTGCCAGGCTCTGCTAAAA-3





The genes encoding c-IAP1 and c-IAP2 lie in close proximity
(∼2.5 Mb) to that encoding caspase 11 on mouse chromosome
9 (Figure 1A). Since both c-IAP genes have been targeted
previously using ES cell lines derived from 129 mice, we sought
to examine the caspase 11 status of these mice. Sequence analysis
from genomic DNA revealed that c-IAP1
−/− mice also contain
the mutant caspase 11 locus, despite the fact that these mice
have been extensively backcrossed into the caspase 11 wild-
type mouse stain, C57BL/6 (Figure 1B). In contrast, even with
the close proximity of the c-IAP2 and caspase 11 genes, the
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Figure 2 c-IAP1−/− MEFs are unable to induce caspase 11 in response to
LPS
(A) c-IAP1+/+ or c-IAP1−/− MEFs were exposed to 0.1mg/ml LPS (+) or 1mg/ml LPS
(++) for 6 h before lysis. Whole-cell lysates were prepared and Western blot analysis was
conducted for the levels of caspase 11, c-IAP1 or β-actin. Molecular masses are indicated in
kDa. The asterisk (*) indicates a non-speciﬁc protein recognized by the anti-c-IAP1 antibody.
(B) c-IAP1+/+ or c-IAP1−/− MEFs were treated as in (A). RNA was extracted and subjected
to RT–PCR analysis for full-length caspase 11. Sizes are indicated in bp. wt, wild-type. (C)
Wild-type MEFs were pre-treated with the Smac (second mitochondrial-derived activator of
caspase) mimetic AEG40730 (50nM) for 30min (SM), before being exposed to LPS for 6 h.
Whole-cell lysates were prepared and Western blot analysis was conducted for the levels of
caspase 11, c-IAP1 or β-actin. Molecular masses are indicated in kDa. Casp, caspase.
c-IAP2
−/− mice tested did not carry the caspase 11 deletion
(Figure 1B).
Considerable heterogeneity exists within 129 mice used to
derive many of the ES cell lines used for targeted mutagenesis,
thus creating multiple individual substrains [1]. Although the c-
IAP1 and c-IAP2 genes were both targeted in 129 ES cell lines,
these lines were derived from different 129 substrains [12,14].
Therefore the unexpected differences between mice targeted
for c-IAP1 and c-IAP2 might potentially have occurred due to
differences in the ES lines used for their construction.
To explore the possibility the caspase 11 mutation might only
occur in a subset of 129 strains, caspase 11 was sequenced in
an extensive panel of 129-derived ES lines extending across
different lineages. The relevant region of the caspase 11 gene
was sequenced in multiple 129-derived ES cell lines, including
the 129 P2 and 129 X1 lines which were used to target the c-
IAP1 and c-IAP2 genes respectively [12,14]. All 129-derived ES
cell lines tested harboured the mutation in the caspase 11 locus,
suggestingthatthisisatruereﬂectionofthe129strain,ratherthan
a genetic peculiarity of a lineage of substrains (Figure 1C). This
suggests that the c-IAP2, but not the c-IAP1 locus, has separated
from the mutant caspase 11 locus in the course of backcrossing.
This mutation is speciﬁc to the 129 strain, because two ES cell
lines derived from C57BL/6 mice, Bruce4 and JM8.N4, were
found to be wild-type for the caspase 11 locus (Figure 1C).
Caspase 11 cannot be readily detected in resting cells, but
is induced by inﬂammatory stimuli such as LPS [4]. Caspase
11 induction in wild-type MEFs was compared with matched
c-IAP1
−/− littermates,inwhichc-IAP1deﬁciencywasconﬁrmed
by immunoblot analysis (Figure 2A). When MEFs were exposed
to bacterial LPS, wild-type cells demonstrated a robust induction
of pro-caspase 11, as predicted, but c-IAP1
−/− MEFs lacked
detectable caspase 11 (Figure 2A). To determine whether this
was due to the splicing defect predicted by the 5 bp deletion
described previously [2], rather than a c-IAP1-dependent defect
inthesignallingpathwaydrivingcaspase11expression,RT–PCR
was performed on RNA harvested from wild-type or c-IAP1
−/−
MEFs, following LPS stimulation. Primers designed to amplify
full-length caspase 11 mRNA recovered only a truncated form of
caspase 11 cDNA in c-IAP1
−/− MEFs ( 110) exposed to LPS,
as compared with the wild-type controls (Figure 2B), consistent
with c-IAP1-deﬁcient MEFs harbouring the somatic mutation in
their caspase 11-coding sequence (Figure 1C).
To exclude further the possibility that c-IAP1 participates in
the LPS-dependent induction of caspase 11, MEFs were exposed
to AEG40730, an IAP antagonist that rapidly depletes cells of c-
IAP1,c-IAP2andXIAP(X-linkedinhibitorofapoptosis)[17,18].
As expected, c-IAP1 protein levels were abrogated in wild-type
MEFs treated with the IAP antagonist, as conﬁrmed by Western
blot analysis (Figure 2C). Importantly, LPS-induced expression
of caspase 11 was unaltered in MEFs chemically depleted of
c-IAP1, suggesting that, in these cells, c-IAP1 is dispensable for
the induction of pro-caspase 11 (Figure 2C).
DISCUSSION
The ﬁndings described above suggest that the mice created by
targeting c-IAP1 in a 129-derived ES cell line [12] contain
an added layer of complexity if used to investigate roles of
c-IAP1 in innate immunity and programmed cell death, because
of a concealed defect in the caspase 11 gene (Figure 1B). It
should be noted that, in that original study, the primary phenotype
observed in c-IAP1
−/− cells was a marked stabilization of
c-IAP2, a result conﬁrmed subsequently by Darding et al. ([19]
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and references therein), indicating that this effect is independent
of caspase 11 status. However, a role for c-IAP1 in the regulation
of the innate immunity is not ruled out. Indeed, in Drosophila,
an IAP orthologue termed DIAP2 (Drosphila IAP2) is critical for
activationofinnateimmuneresponsesmediatedbyIMD(immune
deﬁciency), the Drosophila orthologue of mammalian RIPK1
(receptor-interacting serine/threonine protein kinase 1) [20–24].
Furthermore, the syntenic nature of the c-IAP, caspase 1 and
caspase 11 genes may represent a functional gene cluster. This
synteny is also conserved in humans with caspases 4 and 5, the
human orthologues of murine caspase 11, closely linked to the
c-IAP genes.
Intriguingly, the caspase 11 defect was not detected in the
c-IAP2
−/− mice, despite the close proximity of the genes
encoding caspase 11, c-IAP1 and c-IAP2 on mouse chromosome
9. This was not due to differences in the cell lines used in their
construction, since ES cells derived from both 129 P2 and the
129 X1 mice, which were used to target c-IAP1 and c-IAP2
genes respectively, contain the mutation in the caspase 11 gene
(Figure 1C). This suggests that in c-IAP2
−/− mice, the caspase
11 and c-IAP2 alleles have recombined over successive crosses
into the C57BL/6 background. It is intriguing that all of the c-
IAP2
−/− mice are invariably homozygous for wild-type caspase
11,suggestingthatthecrossovereventmusthaveoccurredatleast
twice within the population to become the predominant genotype
in the c-IAP2
−/− colony. These observations suggest that there
may be a selective advantage for expression of the wild-type
caspase 11 gene during murine development. Since the c-IAP1
locus is closer to that of caspase 11 (Figure 1A), the likelihood of
thiscrossovereventmaybemorerare,ortheselectivepressurefor
wild-type caspase 11 may only exist in the context of the c-IAP2
deletion.
Although the c-IAP2-deﬁcient mice tested in the present study
were found to be wild-type for caspase 11, the point at which
the c-IAP2
−/− and mutant caspase 11 loci separated is unknown.
Clearly, in vivo studies to elucidate the role of c-IAP1 in the
innate immune response, or indeed to study cell death, should
ideallybeperformedinabackgroundthatiswild-typeforcaspase
11. Fortunately, this model currently exists. An elegant murine
model has been described recently that facilitates independent or
simultaneous inactivation of the linked c-IAP1 and c-IAP2 genes
[25]. Importantly, these mice were generated using the C57BL/6
ES cell line Bruce4, which we have demonstrated does not carry
the caspase 11 mutation (Figure 1C).
The present study has focused on the linkage between c-IAP1,
c-IAP2 and the caspase 11 mutation carried from the constructed
129 ES cells. However, it is important to note that other genetic
knockouts derived from the 129 ES cells may be inadvertently
carrying the concealed mutation within the caspase 11 locus.
Since the gene for caspase 12 (Casp12) is in close proximity
to that of caspase 11 on mouse chromosome 9 (Figure 1A),
it might be helpful to test mice experimentally targeted
for caspase 12 constructed using a 129-derived ES cell line for
the caspase 11 mutation [26]. Caspase 12 has subsequently been
targeted in a C57BL/6-derived ES cell line [27], and this strain
may be more appropriate for studying caspase 12 function as the
wild-type status of caspase 11 has been conﬁrmed [27].
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